Abstract
The incidence of Alzheimer’s disease (AD) increases significantly following chronic stress and brain ischemia which, over the years, cause accumulation of toxic amyloid species and brain damage. The effects of global 15-min ischemia and 120-min reperfusion on the levels of expression of the amyloid precursor protein (APP) and its processing were investigated in the brain cortex (Cx) of male Wistar rats. Additionally, the levels of expression of the amyloid-degrading enzymes neprilysin (NEP), endothelin-converting enzyme-1 (ECE-1), and insulin-degrading enzyme (IDE), as well as of some markers of oxidative damage were assessed. It was shown that the APP mRNA and protein levels in the rat Cx were significantly increased after the ischemic insult. Protein levels of the soluble APP fragments, especially of sAPPβ produced by β-secretase, (BACE-1) and the levels of BACE-1 mRNA and protein expression itself were also increased after ischemia. The protein levels of APP and BACE-1 in the Cx returned to the control values after 120-min reperfusion. The levels of NEP and ECE-1 mRNA also decreased after ischemia, which correlated with the decreased protein levels of these enzymes. However, we have not observed any changes in the protein levels of insulin-degrading enzyme. Contents of the markers of oxidative damage (di-tyrosine and lysine conjugates with lipid peroxidation products) were also increased after ischemia. The obtained data suggest that ischemia shifts APP processing towards the amyloidogenic β-secretase pathway and accumulation of the neurotoxic Aβ peptide as well as triggers oxidative stress in the cells. These results are discussed in the context of the role of stress and ischemia in initiation and progression of AD.
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer’s disease
- APP:
-
amyloid precursor protein
- BACE1:
-
β-secretase
- Cx:
-
cortex
- ECE-1:
-
endothelin-converting enzyme-1
- IDE:
-
insulin-degrading enzyme
- NEP:
-
neprilysin
References
Escher, C. M., Sannemann, L., and Jessen, F. (2019) Stress and Alzheimer’s disease, J. Neural. Transm (Vienna), 126, 1155-1161, https://doi.org/10.1007/s00702-019-01988-z.
Sotiropoulos, I., Silva, J. M., Gomes, P., Sousa, N., and Almeida, O. F. X. (2019) Stress and the etiopathogenesis of Alzheimer’s disease and depression, Adv. Exp. Med. Biol., 1184, 241-257, https://doi.org/10.1007/978-981-32-9358-8_20.
Kotlęga, D., Gołąb-Janowska, M., Masztalewicz, M., Ciećwież, S., and Nowacki, P. (2016) The emotional stress and risk of ischemic stroke, Neurol. Neurochir. Pol., 50, 265-270.
Daulatzai, M. A. (2017) Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer’s disease, J. Neurosci. Res., 95, 943-972, https://doi.org/10.1002/jnr.23777.
Dong, S., Maniar, S., Manole, M. D., and Sun, D. (2018) Cerebral hypoperfusion and other shared brain pathologies in ischemic stroke and Alzheimer’s disease, Transl. Stroke Res., 9, 238-250, https://doi.org/10.1007/s12975-017-0570-2.
Ułamek-Kozioł, M., Pluta, R., Januszewski, S., Kocki, J., Bogucka-Kocka, A., and Czuczwar, S. J. (2016) Expression of Alzheimer’s disease risk genes in ischemic brain degeneration, Pharmacol. Rep., 68, 1345-1349, https://doi.org/10.1016/j.pharep.2016.09.006.
Pluta, R., Ułamek-Kozioł, M., Januszewski, S., and Czuczwar, S. J. (2020) shared genomic and proteomic contribution of amyloid and tau protein characteristic of Alzheimer’s disease to brain ischemia, Int. J. Mol. Sci., 21, 3186, https://doi.org/10.3390/ijms21093186.
Bisht, K., Sharma, K., and Tremblay, M. È. (2018) Chronic stress as a risk factor for Alzheimer’s disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress, Neurobiol. Stress, 9, 9-21, https://doi.org/10.1016/j.ynstr.2018.05.003.
Canet, G., Hernandez, C., Zussy, C., Chevallier, N., Desrumaux, C., and Givalois, L. (2019) Is AD a stress-related disorder? Focus on the HPA axis and its promising therapeutic targets, Front. Aging Neurosci., 11, 269, https://doi.org/10.3389/fnagi.2019.00269.
Gulyaeva, N. V. (2019) Functional neurochemistry of the ventral and dorsal hippocampus: stress, depression, dementia and remote hippocampal damage, Neurochem. Res., 44, 1306-1322, https://doi.org/10.1007/s11064-018-2662-0.
Podgorny, O. V., and Gulyaeva, N. V. (2020) Glucocorticoid-mediated mechanisms of hippocampal damage: contribution of subgranular neurogenesis, J. Neurochem., https://doi.org/10.1111/jnc.15265.
Gulyaeva, N. V. (2019) Biochemical mechanisms and translational relevance of hippocampal vulnerability to distant focal brain injury: the price of stress response, Biochemistry (Moscow), 84, 1306-1328, https://doi.org/10.1134/S0006297919110087.
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E. (2011) Alzheimer’s disease, Lancet, 377, 1019-1031, https://doi.org/10.1016/S0140-6736(10)61349-9.
Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics, Science, 297, 353-356, https://doi.org/10.1126/science.1072994.
Walton, C. C., Begelman, D., Nguyen, W., and Andersen, J. K. (2020) Senescence as an amyloid cascade: the amyloid senescence hypothesis, Front. Cell. Neurosci., 14, 129, https://doi.org/10.3389/fncel.2020.00129.
Walsh, D. M., Hartley, D. M., Condron, M. M., Selkoe, D. J., and Teplow, D. B. (2001) In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692→Gly) Alzheimer’s disease, Biochem. J., 355, 869-877, https://doi.org/10.1042/bj3550869.
Ferreira, S. T., Lourenco, M. V., Oliveira, M. M., and De Felice, F. G. (2015) Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease, Front. Cell. Neurosci., 9, 191, https://doi.org/10.3389/fncel.2015.00191.
Kobayashi, K., Hayashi, M., Nakano, H., Shimazaki, M., Sugimori, K., and Koshino, Y. (2004) Correlation between astrocyte apoptosis and Alzheimer changes in gray matter lesions in Alzheimer’s disease, J. Alzheimers Dis., 6, 623-632, https://doi.org/10.3233/jad-2004-6606.
Kuhla, A., Ludwig, S. C., Kuhla, B., Münch, G., and Vollmar, B. (2015) Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer’s disease brain, Neurobiol. Aging, 36, 753-761, https://doi.org/10.1016/j.neurobiolaging.2014.09.025.
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., et al. (1999) Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE, Science, 286, 735-741, https://doi.org/10.1126/science.286.5440.735.
Wolfe, M. S., Xia, W., Moore, C. L., Leatherwood, D. D., Ostaszewski, B., et al. (1999) Peptidomimetic probes and molecular modeling suggest that Alzheimer’s gamma-secretase is an intramembrane-cleaving aspartyl protease, Biochemistry, 38, 4720-4727, https://doi.org/10.1021/bi982562p.
Belyaev, N. D., Kellett, K. A., Beckett, C., Makova, N. Z., Revett, T. J., et al. (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a β-secretase-dependent pathway, J. Biol. Chem., 285, 41443-41454, https://doi.org/10.1074/jbc.M110.141390.
Beckett, C., Nalivaeva, N. N., Belyaev, N. D., and Turner, A. J. (2012) Nuclear signalling by membrane protein intracellular domains: the AICD enigma, Cell. Signal., 24, 402-409, https://doi.org/10.1016/j.cellsig.2011.10.007.
Parvathy, S., Hussain, I., Karran, E. H., Turner, A. J., and Hooper, N. M. (1999) Cleavage of Alzheimer’s amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells, Biochemistry, 38, 9728-9734, https://doi.org/10.1021/bi9906827.
Allinson, T. M., Parkin, E. T., Turner, A. J., and Hooper, N. M. (2003) ADAMs family members as amyloid precursor protein alpha-secretases, J. Neurosci. Res., 74, 342-352, https://doi.org/10.1002/jnr.10737.
Asai, M., Hattori, C., Szabó, B., Sasagawa, N., Maruyama, K., Tanuma, S., and Ishiura, S. (2003) Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase, Biochem. Biophys. Res. Commun., 301, 231-235, https://doi.org/10.1016/s0006-291x(02)02999-6.
Octave, J.-N., Pierrot, N., Santos, S. F., Nalivaeva, N. N., and Turner, A. J. (2013) From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein, J. Neurochem., 126, 183-190, https://doi.org/10.1111/jnc.12239.
Chasseigneaux, S., and Allinquant, B. (2012) Functions of Aβ, sAPPα and sAPPβ: similarities and differences, J. Neurochem., 120 Suppl. 1, 99-108, https://doi.org/10.1111/j.1471-4159.2011.07584.x.
Nalivaeva, N. N., and Turner, A. J. (2019) Targeting amyloid clearance in Alzheimer’s disease as a therapeutic strategy, Br. J. Pharmacol., 176, 3447-3463, https://doi.org/10.1111/bph.14593.
Eckman, E. A., Adams, S. K., Troendle, F. J., Stodola, B. A., Kahn, M. A., et al. (2006) Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme, J. Biol. Chem., 281, 30471-30478, https://doi.org/10.1074/jbc.M605827200.
Nalivaeva, N. N., Beckett, C., Belyaev, N. D., and Turner, A. J. (2012) Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease? J. Neurochem., 120, Suppl. 1, 167-185, https://doi.org/10.1111/j.1471-4159.2011.07510.x.
Miners, J. S., Palmer, J. C., Tayler, H., Palmer, L. E., Ashby, E., et al. (2014) Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes, Front. Aging Neurosci., 6, 238, https://doi.org/10.3389/fnagi.2014.00238.
Di Marco, L. Y., Farkas, E., Martin, C., Venneri, A., and Frangi, A. F. (2015) Is vasomotion in cerebral arteries impaired in Alzheimer’s disease? J. Alzheimer’s Dis., 46, 35-53, https://doi.org/10.3233/JAD-142976.
Nalivaeva, N. N., and Turner, A. J. (2017) Role of ageing and oxidative stress in regulation of amyloid-degrading enzymes and development of neurodegeneration, Curr. Aging Sci., 10, 32-40, https://doi.org/10.2174/1874609809666161111101111.
Shi, X., Ohta, Y., Liu, X., Shang, J., Morihara, R., et al. (2019) Chronic cerebral hypoperfusion activates the coagulation and complement cascades in Alzheimer’s disease mice, Neuroscience, 416, 126-136, https://doi.org/10.1016/j.neuroscience.2019.07.050.
Morgese, M. G., Schiavone, S., and Trabace, L. (2017) Emerging role of amyloid beta in stress response: implication for depression and diabetes, Eur. J. Pharmacol., 817, 22-29, https://doi.org/10.1016/j.ejphar.2017.08.031.
Mouri, A., Zou, L. B., Iwata, N., Saido, T. C., Wang, D., et al. (2006) Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory, Behav. Brain Res., 168, 83-91, https://doi.org/10.1016/j.bbr.2005.10.014.
Devi, L., and Ohno, M. (2015) A combination Alzheimer’s therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice, Mol. Brain, 8, 19, https://doi.org/10.1186/s13041-015-0110-5.
Poirier, R., Wolfer, D. P., Welzl, H., Tracy, J., Galsworthy, M. J., et al. (2006) Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit, Neurobiol. Dis., 24, 475-483, https://doi.org/10.1016/j.nbd.2006.08.003.
Bakthavachalam, P., and Shanmugam, P. S. T. (2017) Mitochondrial dysfunction – Silent killer in cerebral ischemia, J. Neurol. Sci., 375, 417-423, https://doi.org/10.1016/j.jns.2017.02.043.
Butterfield, D. A. (2002) Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer’s disease brain. A review, Free Radic. Res., 36, 1307-1313, https://doi.org/10.1080/1071576021000049890.
Angelova, P. R., and Abramov, A. Y. (2014) Interaction of neurons and astrocytes underlies the mechanism of Abeta-induced neurotoxicity, Biochem. Soc. Trans., 42, 1286-1290, https://doi.org/10.1042/BST20140153.
Babusikova, E., Hatok, J., Dobrota, D., and Kaplan, P. (2007) Age-related oxidative modifications of proteins and lipids in rat brain, Neurochem. Res., 32, 1351-1356, https://doi.org/10.1007/s11064-007-9314-0.
Umeno, A., Biju, V., and Yoshida, Y. (2017) In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer’s disease, Parkinson’s disease, and diabetes, Free Radic Res., 51, 413-427, https://doi.org/10.1080/10715762.2017.1315114.
Butterfield, D. A., Reed, T., Newman, S. F., and Sultana, R. (2007) Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer’s disease and mild cognitive impairment, Free Radic. Biol. Med., 43, 658-677, https://doi.org/10.1016/j.freeradbiomed.2007.05.037.
Nanetti, L., Raffaelli, F., Vignini, A., Perozzi, C., Silvestrini, M., et al. (2011) Oxidative stress in ischaemic stroke, Eur. J. Clin. Invest., 41, 1318-1322, https://doi.org/10.1111/j.1365-2362.2011.02546.x.
Hawkins, C. L., and Davies, M. J. (2019) Detection, identification, and quantification of oxidative protein modifications, J. Biol. Chem., 294, 19683-19708, https://doi.org/10.1074/jbc.REV119.006217.
Sies, H., and Jones, D. P. (2020) Reactive oxygen species (ROS) as pleiotropic physiological signalling agents, Nat. Rev. Mol. Cell. Biol., 21, 363-383, https://doi.org/10.1038/s41580-020-0230-3.
Nissanka, N., and Moraes, C. T. (2018) Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease, FEBS Lett., 592, 728-742, https://doi.org/10.1002/1873-3468.12956.
Assi, M. (2017) The differential role of reactive oxygen species in early and late stages of cancer, Am. J. Physiol. Regul. Integr. Comp. Physiol., 313, R646-R653, https://doi.org/10.1152/ajpregu.00247.2017.
Petersen, D. R., and Doorn, J. A. (2004) Reactions of 4-hydroxynonenal with proteins and cellular targets, Free Radic. Biol. Med., 37, 937-945, https://doi.org/10.1016/j.freeradbiomed.2004.06.012.
Kilkenny, C., Browne, W., Cuthill, I., Emerson, M., and Altman, D. (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, PLoS Biol., 8, e1000412, https://doi.org/10.1371/journal.pbio.1000412.
Pulsinelli, W. A., and Buchan, A. M. (1988) The four-vessel occlusion rat model: method for complete occlusion of vertebral arteries and control of collateral circulation, Stroke, 19, 913-914, https://doi.org/10.1161/01.str.19.7.913.
Babusíková, E., Kaplán, P., Lehotský, J., Jesenák, M., and Dobrota, D. (2004) Oxidative modification of rat cardiac mitochondrial membranes and myofibrils by hydroxyl radicals, Gen. Physiol. Biophys., 23, 327-335.
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., et al. (1985) Measurement of protein using bicinchoninic acid, Anal. Biochem., 150, 76-85, https://doi.org/10.1016/0003-2697(85)90442-7.
Pluta, R., Kida, E., Lossinsky, A. S., Golabek, A. A., Mossakowski, M. J., and Wisniewski, H. M. (1994) Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer’s beta-amyloid protein precursor in the brain, Brain Res., 649, 323-328, https://doi.org/10.1016/0006-8993(94)91081-2.
Hiltunen, M., Mäkinen, P., Peräniemi, S., Sivenius, J., van Groen, T., et al. (2009) Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus, Neurobiol. Dis., 35, 103-113, https://doi.org/10.1016/j.nbd.2009.04.009.
Koike, M. A., Garcia, F. G., Kitazawa, M., Green, K. N., and Laferla, F. M. (2011) Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia, Neurosci. Lett., 495, 55-59, https://doi.org/10.1016/j.neulet.2011.03.034.
Garcia-Alloza, M., Gregory, J., Kuchibhotla, K. V., Fine, S., Wei, Y., et al. (2011) Cerebrovascular lesions induce transient beta-amyloid deposition, Brain, 134, 3697-3707, https://doi.org/10.1093/brain/awr300.
Pimentel-Coelho, P. M., Michaud, J. P., and Rivest, S. (2013) Effects of mild chronic cerebral hypoperfusion and early amyloid pathology on spatial learning and the cellular innate immune response in mice, Neurobiol. Aging, 34, 679-693, https://doi.org/10.1016/j.neurobiolaging.2012.06.025.
Jendroska, K., Poewe, W., Daniel, S. E., Pluess, J., Iwerssen-Schmidt, H., Paulsen, J., et al. (1995) Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain, Acta Neuropathol., 90, 461-466, https://doi.org/10.1007/BF00294806.
Kövari, E., Herrmann, F. R., Hof, P. R., and Bouras, C. (2013) The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer’s disease, Neuropathol. Appl. Neurobiol., 39, 498-509, https://doi.org/10.1111/nan.12003.
Fraser, P. E., Nguyen, J. T., Inouye, H., Surewicz, W. K., Selkoe, D. J., et al. (1992) Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein, Biochemistry, 31, 10716-10723, https://doi.org/10.1021/bi00159a011.
Nalivaeva, N. N., Fisk, L., Kochkina, E. G., Plesneva, S. A., Zhuravin, I. A., et al. (2004) Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes, Ann. N. Y. Acad. Sci., 1035, 21-33, https://doi.org/10.1196/annals.1332.002.
Badan, I., Dinca, I., Buchhold, B., Suofu, Y., Walker, L., et al. (2004) Accelerated accumulation of N- and C-terminal β-APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats, Eur. J. Neurosci., 19, 2270-2280, https://doi.org/10.1111/j.0953-816X.2004.03323.x.
Cai, Z., Liu, Z., Xiao, M., Wang, C., and Tian, F. (2017) Chronic cerebral Hypoperfusion promotes amyloid-beta pathogenesis via activating β/γ-secretases, Neurochem. Res., 42, 3446-3455, https://doi.org/10.1007/s11064-017-2391-9.
Nalivaeva, N. N., Babusikova, E. B., Dobrota, D., and Turner, A. J. (2005) Effect of ischaemia and reperfusion on the content and degradaiton of amyloid precursor Protein in the hippoampus of rats, Neirokhimia, 22, 207-212.
Pluta, R., Kocki, J., Ułamek-Kozioł, M., Petniak, A., Gil-Kulik, P., et al. (2016) Discrepancy in expression of beta-secretase and amyloid-beta protein precursor in Alzheimer-related genes in the rat medial temporal lobe cortex following transient global brain ischemia, J. Alzheimer’s Dis., 51, 1023-1031, https://doi.org/10.3233/JAD-151102.
Kocki, J., Ułamek-Kozioł, M., Bogucka-Kocka, A., Januszewski, S., Jabłoński, M., et al. (2015) Dysregulation of amyloid-β protein precursor, β-Secretase, presenilin 1 and 2 genes in the rat selectively vulnerable CA1 subfield of hippocampus following transient global brain ischemia, J. Alzheimer’s Dis., 47, 1047-1056, https://doi.org/10.3233/JAD-150299.
Petcu, E. B., Sfredel, V., Platt, D., Herndon, J. G., Kessler, C., and Popa-Wagner, A. (2008) Cellular and molecular events underlying the dysregulated response of the aged brain to stroke: a mini-review, Gerontology, 54, 6-17, https://doi.org/10.1159/000112845.
Nalivaeva, N. N., Vasilev, D. S., Dubrovskaya, N. M., Turner, A. J., and Zhuravin, I. A. (2020) Role of neprilysin in synaptic plasticity and memory, Russ. J. Physiol., 106, 1191-1208, https://doi.org/10.31857/S0869813920100076.
Bai, H. Y., Mogi, M., Nakaoka, H., Kan-No, H., Tsukuda, K., et al. (2015) Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage, Eur. J. Pharmacol., 762, 293-298, https://doi.org/10.1016/j.ejphar.2015.05.059.
Haynes, R., Zhu, D., Judge, P. K., Herrington, W. G., Kalra, P. A., and Baigent, C. (2020) Chronic kidney disease, heart failure and neprilysin inhibition, Nephrol. Dial. Transplant., 35, 558-564, https://doi.org/10.1093/ndt/gfz058.
Newell, A. J., Sue, L. I., Scott, S., Rauschkolb, P. K., Walker, D. G., et al. (2003) Thiorphan-induced neprilysin inhibition raises amyloid beta levels in rabbit cortex and cerebrospinal fluid, Neurosci. Lett., 350, 178-180, https://doi.org/10.1016/s0304-3940(03)00902-9.
Li, W., Wu, Y., Min, F., Li, Z., Huang, J., and Huang, R. (2010) A nonhuman primate model of Alzheimer’s disease generated by intracranial injection of amyloid-beta42 and thiorphan, Metab. Brain Dis., 25, 277-284, https://doi.org/10.1007/s11011-010-9207-9.
Belyaev, N. D., Nalivaeva, N. N., Makova, N. Z., and Turner, A. J. (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer’s disease, EMBO Rep., 10, 94-100, https://doi.org/10.1038/embor.2008.222.
Venugopal, C., Pappolla, M. A., and Sambamurti, K. (2007) Insulysin cleaves the APP cytoplasmic fragment at multiple sites, Neurochem. Res., 32, 2225-2234, https://doi.org/10.1007/s11064-007-9449-z.
García de la Cadena, S., and Massieu, L. (2016) Caspases and their role in inflammation and ischemic neuronal death. Focus on caspase-12, Apoptosis, 21, 763-777, https://doi.org/10.1007/s10495-016-1247-0.
Kozlova, D. I., Vasylev, D. S., Dubrovskaya, N. M., Nalivaeva, N. N., Tumanova, N. L., and Zhuravin, I. A. (2015) Role of caspase-3 in regulation of the amyloid-degrading neuropeptidase neprilysin level in the rat cortex after hypoxia, J. Evol. Biochem. Physiol., 51, 480-484, https://doi.org/10.1134/S0022093015060046.
Chang, C. Z., Yen, C. P., Winadi, D., Wu, S. C., Howng, S. L., et al. (2004) Neuroprotective effect of CGS 26303, an endothelin-converting enzyme inhibitor, on transient middle cerebral artery occlusion in rats, J. Cardiovasc. Pharmacol., 44, Suppl. 1, 487-489, https://doi.org/10.1097/01.fjc.0000166307.86678.d1.
Li, R., Cui, M., Zhao, J., Yu, M., Ying, Z., Zhou, S., and Zhou, H. (2013) Association of endothelin-converting enzyme-1b C-338A polymorphism with increased risk of ischemic stroke in Chinese Han population, J. Mol. Neurosci., 51, 485-492, https://doi.org/10.1007/s12031-013-0100-y.
Rodrigo, R., Fernández-Gajardo, R., Gutiérrez, R., Matamala, J. M., Carrasco, R., et al. (2013) Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities, CNS Neurol. Disord. Drug Targets, 12, 698-714, https://doi.org/10.2174/1871527311312050015.
Urikova, A., Babusikova, E., Dobrota, D., Drgova, A., Kaplan, P., et al. (2006) Impact of Ginkgo Biloba Extract EGb 761 on ischemia/reperfusion – induced oxidative stress products formation in rat forebrain, Cell. Mol. Neurobiol., 26, 1343-1353, https://doi.org/10.1007/s10571-006-9030-3.
Quan, H., Koltai, E., Suzuki, K., Aguiar, A. S. Jr., Pinho, R., et al. (2020) Exercise, redox system and neurodegenerative diseases, Biochim. Biophys. Acta Mol. Basis Dis., 1866, 165778, https://doi.org/10.1016/j.bbadis.2020.165778.
Zhuravin, I. A., Dubrovskaya, N. M., Vasilev, D. S., Kozlova, D. I., Kochkina, E. G., et al. (2019) Regulation of neprilysin activity and cognitive functions in rats after prenatal hypoxia, Neurochem. Res., 44, 1387-1398, https://doi.org/10.1007/s11064-019-02796-3.
Acknowledgments
The authors are grateful to J. Bencatova, Z. Cetlova, and A. Kempna for help in conducting experiments.
Funding
Supported by grants FP7-PEOPLE-2010-IEF, MRC, ARUK, VEGA 1/0266/18 and partially by Russian Foundation for Basic Research (grant 19-015-00232) and Russian Federation state budget (assignment АААА-А18-118012290373-7).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflict of interests in financial or any other sphere. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Rights and permissions
About this article
Cite this article
Babusikova, E., Dobrota, D., Turner, A.J. et al. Effect of Global Brain Ischemia on Amyloid Precursor Protein Metabolism and Expression of Amyloid-Degrading Enzymes in Rat Cortex: Role in Pathogenesis of Alzheimer’s Disease. Biochemistry Moscow 86, 680–692 (2021). https://doi.org/10.1134/S0006297921060067
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297921060067